Receptors, Urokinase Plasminogen Activator
"Receptors, Urokinase Plasminogen Activator" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An extracellular receptor specific for UROKINASE-TYPE PLASMINOGEN ACTIVATOR. It is attached to the cell membrane via a GLYCOSYLPHOSPHATIDYLINOSITOL LINKAGE and plays a role in the co-localization of urokinase-type plasminogen activator with PLASMINOGEN.
| Descriptor ID |
D055293
|
| MeSH Number(s) |
D12.776.395.550.448.813 D12.776.543.484.500.813 D12.776.543.550.418.813 D12.776.543.750.815
|
| Concept/Terms |
Receptors, Urokinase Plasminogen Activator- Receptors, Urokinase Plasminogen Activator
- CD87 Antigen
- Antigen, CD87
- Plasminogen Activator Receptor, Urokinase Type
- Plasminogen Activator, Urokinase Receptor
- Urokinase-Type Plasminogen Activator Receptors
- Urokinase Type Plasminogen Activator Receptors
- Receptor, Pro-Urokinase
- Pro-Urokinase Receptor
- Receptor, Pro Urokinase
- Receptor, Urokinase Plasminogen Activator
- U-PA Receptor
- Receptor, U-PA
- U PA Receptor
- Upar Receptor
- Receptor, Upar
- Urokinase Plasminogen Activator Receptors
- Antigens, CD87
- CD87 Antigens
- Plasminogen Activator, Urokinase Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Urokinase Plasminogen Activator".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Urokinase Plasminogen Activator".
This graph shows the total number of publications written about "Receptors, Urokinase Plasminogen Activator" by people in this website by year, and whether "Receptors, Urokinase Plasminogen Activator" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Urokinase Plasminogen Activator" by people in Profiles.
-
The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease. Sci Transl Med. 2023 09 20; 15(714):eabq6492.
-
Soluble Urokinase Plasminogen Activator Receptor: Genetic Variation and Cardiovascular Disease Risk in Black Adults. Circ Genom Precis Med. 2021 12; 14(6):e003421.
-
Effect of Sickle Cell Trait and APOL1 Genotype on the Association of Soluble uPAR with Kidney Function Measures in Black Americans. Clin J Am Soc Nephrol. 2021 02 08; 16(2):287-289.
-
Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situ. Breast Cancer Res. 2017 05 15; 19(1):56.
-
Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death. Circ Cardiovasc Qual Outcomes. 2017 03; 10(3).
-
Soluble Urokinase Receptor and Chronic Kidney Disease. N Engl J Med. 2015 Nov 12; 373(20):1916-25.
-
Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events. J Am Heart Assoc. 2014 10 23; 3(5):e001118.
-
Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy. Mol Cancer Ther. 2013 Dec; 12(12):2628-39.
-
Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis. Clin Cancer Res. 2011 Feb 01; 17(3):459-71.
-
Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer. Mol Cancer Res. 2007 May; 5(5):485-96.